JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M201557200 on March 28, 2002

J. Biol. Chem., Vol. 277, Issue 23, 20490-20498, June 7, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/23/20490    most recent
M201557200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hernández-Acosta, P.
Right arrow Articles by Kupke, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hernández-Acosta, P.
Right arrow Articles by Kupke, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular Characterization of the Arabidopsis thaliana Flavoprotein AtHAL3a Reveals the General Reaction Mechanism of 4'-Phosphopantothenoylcysteine Decarboxylases*

Pilar Hernández-AcostaDagger , Dietmar G. Schmid§, Günther Jung§, Francisco A. Culiáñez-MaciàDagger , and Thomas Kupke||

From the Dagger  Instituto de Biología Molecular y Celular de Plantas, Universidad Politécnica de Valencia-CSIC, Camino de Vera s/n, 46022 Valencia, Spain, § Institut für Organische Chemie, Universität Tübingen, Auf der Morgenstelle 18, 72076 Tübingen, and  Lehrstuhl für Mikrobielle Genetik, Universität Tübingen, Auf der Morgenstelle 15, Verfügungsgebäude, 72076 Tübingen, Germany

Received for publication, February 15, 2002, and in revised form, March 25, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The Arabidopsis thaliana flavoprotein AtHAL3a, which is linked to plant growth and salt and osmotic tolerance, catalyzes the decarboxylation of 4'-phosphopantothenoylcysteine to 4'-phosphopantetheine, a key step in coenzyme A biosynthesis. AtHAL3a is similar in sequence and structure to the LanD enzymes EpiD and MrsD, which catalyze the oxidative decarboxylation of peptidylcysteines. Therefore, we hypothesized that the decarboxylation of 4'-phosphopantothenoylcysteine also occurs via an oxidatively decarboxylated intermediate containing an aminoenethiol group. A set of AtHAL3a mutants were analyzed to detect such an intermediate. By exchanging Lys34, we found that AtHAL3a is not only able to decarboxylate 4'-phosphopantothenoylcysteine but also pantothenoylcysteine to pantothenoylcysteamine. Exchanging residues within the substrate binding clamp of AtHAL3a (for example of Gly179) enabled the detection of the proposed aminoenethiol intermediate when pantothenoylcysteine was used as substrate. This intermediate was characterized by its high absorbance at 260 and 280 nm, and the removal of two hydrogen atoms and one molecule of CO2 was confirmed by ultrahigh resolution mass spectrometry. Using the mutant AtHAL3a C175S enzyme, the product pantothenoylcysteamine was not detectable; however, oxidatively decarboxylated pantothenoylcysteine could be identified. This result indicates that reduction of the aminoenethiol intermediate depends on a redox-active cysteine residue in AtHAL3a.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The biosynthesis of coenzyme A from pantothenate includes the decarboxylation of (R)-4'-phospho-N-pantothenoylcysteine (PPC)1 to 4'-phosphopantetheine (PP), a reaction that introduces the reactive cysteamine residue of coenzyme A. In eubacteria, the decarboxylation of PPC is catalyzed by the NH2-terminal CoaC domain of the Dfp proteins (1, 2). Dfp is a bifunctional enzyme, and the COOH-terminal CoaB domain catalyzes the synthesis of PPC from 4'-phosphopantothenate and L-cysteine using cytidine 5'-triphosphate as the activating nucleotide (3). The coenzyme A biosynthetic pathway in plants is not fully understood. However, it was recently shown that the Arabidopsis thaliana trimeric flavoprotein AtHAL3a, which is linked to plant growth and salt and osmotic tolerance (4), catalyzes the same reaction as the CoaC domain of Dfp, the decarboxylation of PPC (5).

Dfp and AtHAL3a belong to a new family of flavoproteins that was named HFCD (homo-oligomeric flavin containing Cys decarboxylases (2, 6)). Other members of this flavoprotein family include the LanD flavoenzymes EpiD and MrsD, which catalyze the oxidative decarboxylation of peptidylcysteines to peptidyl-beta -aminoethenethiols (7-11), a reaction involved in the biosynthesis of lantibiotics containing unsaturated thioether bridges such as epidermin and mersacidin. Lantibiotics are a group of ribosomally synthesized and posttranslationally modified antibiotic peptides containing the thioether amino acid lanthionine and other unusual amino acid residues (12, 13). The structure of the EpiD peptidyl-beta -aminoethenethiol reaction products has been elucidated by NMR spectroscopy and mass spectrometry (9, 14). EpiD, AtHAL3a, and Dfp all bind the cofactor FMN (4, 10, 15), whereas MrsD is a FAD-dependent enzyme (11). The HFCD proteins share the flavin binding motif and conserved active-site residues and are trimeric or dodecameric enzymes catalyzing the decarboxylation of cysteine residues (2, 6).

The crystal structure of an active-site mutant of EpiD with a bound substrate peptide gave the first insight into the decarboxylation mechanism used by the HFCD proteins (6). Surprisingly, it looks like Calpha -Cbeta dehydrogenation is not the initial reaction but rather the oxidation of the thiol group by the flavin cofactor. The spontaneous decarboxylation of the thioaldehyde group-containing intermediate then leads to the peptidylaminoethenethiolate reaction product (6).

The existence of oxidatively decarboxylated reaction products in the case of the LanD enzymes is a direct hint that the homologous PPC decarboxylases also use oxidation of the thiol group to enable decarboxylation of cysteine residues. Therefore, it was concluded that a "peptidyl"-aminoenethiol is an intermediate of the PPC decarboxylases (2, 5) and that this compound is finally reduced to 4'-phosphopantetheine (see Fig. 7). Mechanistic studies on the Dfp enzyme such as detection of substrate/product-induced charge-transfer complexes also favor a mechanism via oxidation of the thiol group and the presence of a thioaldehyde group-containing intermediate (16). However, the existence of this oxidatively decarboxylated intermediate has not been proven, and up to now, the intermediate itself has not been purified or characterized.

The four characterized HFCD proteins EpiD, MrsD, Dfp (CoaC) and AtHAL3a are similar in sequence and the reaction they catalyzed, but they use different substrates, with peptidylcysteines on one hand and 4'-phosphopantothenoylcysteine on the other. Crystal structure analysis of EpiD with bound substrate peptide and a theoretical model for the binding of PPC to AtHAL3a showed that substrate binding involves an NH2-terminal substrate binding helix and a COOH-terminal substrate binding clamp (5, 6). The substrate binding clamp of EpiD forms an antiparallel beta -sheet with the residues SSG (Ser-152 to Gly-154) in the turn region. The binding clamp and substrate peptide together form a three-stranded beta -sheet (6). The substrate binding clamp of the PPC decarboxylases AtHAL3a and Dfp is four residues shorter than that of EpiD and contains a conserved ACGD motif. The conserved Cys residue of this motif (Dfp, Cys158; AtHAL3a, Cys175) aligns with Ser153 of EpiD, and modeling of the AtHAL3a-PPC complex suggests that the conserved Cys residue is in the vicinity of the substrate cysteinyl moiety and might participate in catalysis (5).

For Dfp the substrate binding structural elements have been partially characterized and a PPC decarboxylase signature defined. The conserved lysine residue of the NH2-terminal G(G/S)IAXYK motif of the Dfp proteins is probably important for the binding of the phosphate group of PPC, whereas the exchange of the residue Cys158 led to loss of PPC decarboxylase activity (1).

To elucidate the reaction mechanism of PPC decarboxylases, two central questions have to be answered. First of all, it has to be proven that decarboxylation of PPC involves an oxidatively decarboxylated substrate. Second, elucidation of the mechanism by which this compound is reduced by FMNH2 to complete the reaction cycle of the flavoprotein must occur. To address these questions, we chose the following approach. It should be possible to trap the reaction at the oxidatively decarboxylated intermediate and to prevent complete reduction by changing the geometry between the enzyme-bound intermediate and reduced flavin coenzyme. This could be achieved by changing residues involved in the binding of PPC, such as residues of the NH2-terminal binding helix or the substrate recognition clamp and/or by changing the substrate. Using site-directed mutagenesis, it should also be possible to identify amino acid residues involved in reoxidation of FMNH2 and to trap the intermediate in this way. We decided to carry out these experiments with AtHAL3a, which encodes only the PPC decarboxylase but not the PPC synthetase activity.

Here we present data that AtHAL3a not only decarboxylates PPC but also pantothenoylcysteine (PC) and that the conserved Lys residue of the NH2-terminal binding helix is important for discriminating between phosphorylated and non-phosphorylated substrate. We then show the purification and characterization of oxidatively decarboxylated PC obtained by incubation with mutant AtHAL3a enzymes. Furthermore, we present data indicating that the conserved Cys175 residue is important for reduction of the oxidized intermediate.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Plasmid Construction

In General-- PCR amplifications were performed with Vent-DNA polymerase (New England BioLabs). The entire sequences of the AtHAL3a-coding regions of the constructed plasmids were verified. The oligonucleotides used were purchased from MWG Biotech.

Site-directed Mutagenesis of AtHAL3a-- AtHAL3a mutants were constructed by sequential PCR steps (17) using appropriate mutagenesis primers and pET28a(+)AtHAL3a (4) as template. The primers (i) forward, 5'-GGTGCCGCGCGGCAGCCATATGGCTAG-3', and (ii) reverse, 5'-GGCTTTGTTAGCAGCCGGATCTCAGTG-3' were used as 5'- and 3'-terminal primers for the sequential PCR and bind upstream and downstream of the BamHI and HindIII sites of pET28a(+)AtHAL3a, respectively. The mutant AtHAL3a genes were then cloned into the single BamHI and HindIII sites of the pET28a(+) vector (Novagen) so that a fusion with the His-tag codons occurred. The pET28a(+) derived plasmids were transformed into the expression strain Escherichia coli BL21 (DE3) by electroporation. The pET28a(+)AtHAL3a expression plasmids encode NH2-terminal His-tag fusion proteins of the mutant AtHAL3a proteins (His-AtHAL3a, MGSSHHHHHHSSGLVPRGSHM ASMTGGQQMGRGS-AtHAL3a).

Purification and Characterization of His-AtHAL3a Proteins

Growth of Strains-- The E. coli BL21 (DE3) pET28a(+) AtHAL3a strains were grown at 37 °C in the presence of 100 µg/ml kanamycin to A578 = 0.4 in 0.5 liters of B-broth (10 g of casein hydrolysate 140 (GibcoBRL (Life Technologies)), 5 g of yeast extract (GibcoBRL (Life Technologies)), 5 g of NaCl, 1 g of glucose, and 1 g of K2HPO4/liter, pH 7.3) in 2 liters shaker flasks induced with 1 mM isopropyl-1-thio-beta -D-galactopyranoside and harvested 2 h after induction.

Purification of His-AtHAL3a Proteins-- 500 ml of isopropyl-1-thio-beta -D-galactopyranoside-induced E. coli BL21 (DE3) pET28a(+) AtHAL3a cells were harvested and disrupted by sonication in 10 ml of 20 mM Tris-HCl, pH 8.0. 3 ml of the cleared lysate, obtained by two centrifugation steps (each 20 min at 30,000 × g at 4 °C), was diluted with 3 ml of column buffer (20 mM Tris-HCl, pH 8.0, 10 mM imidazole, 300 mM NaCl) and applied to an equilibrated Ni-NTA column containing ~0.5 ml of Ni-NTA-agarose (Qiagen). The column was then washed with 10 ml of column buffer. His-AtHAL3a and mutant His-AtHAL3a proteins were eluted with column buffer containing 250 mM instead of 10 mM imidazole, and the yellow peak fractions (~400 µl) were collected. If not otherwise stated, immediately after elution from the column, DTT was added to a final concentration of 5 mM. For gel filtration, a 25-µl aliquot of the Ni-NTA eluate was subjected to a Superdex 200 PC 3.2/30 column equilibrated in running buffer (20 mM Tris/HCl, pH 8.0, 200 mM NaCl) at a flow rate 40 µl/min. The Superdex 200 PC 3.2/30 column and the standard proteins used for calibration were obtained from Amersham Pharmacia Biotech. For activity assays (see below), the Ni-NTA eluates were used.

SDS-PAGE-- Proteins were separated using Tricine-sodium dodecyl sulfate-polyacrylamide (10%) gel electrophoresis (18) under reducing conditions.

AtHAL3a Assays-- Approximately 50-100 µg of PPC as a calcium salt (2) were incubated with 0.5-1.0 µg of His-AtHAL3a for 20 min at 37 °C in a total volume of 0.70 ml of 50 mM Tris/HCl, pH 8.0, 5 mM DTT. The decarboxylation of pantothenoylcysteine used as barium salt (2) was assayed in the same way; however, for each assay 475 µg of substrate were used in a total volume of 1 ml. The purity of both substrates was in the range of 60-80%, and it was verified by mass spectrometry that no 4'-phosphopantetheine or pantothenoylcysteamine was present in the synthesized substrates. However, PPC contained minor amounts of the unphosphorylated pantothenoylcysteine. The His-AtHAL3a mutants were adjusted to the same absorbance at 455 nm to enable a direct comparison of their activities. The reaction mixtures were kept at -80 °C and then were successively separated by reversed phase chromatography (RPC) with a µRPC C2/C18 SC 2.1/10 column on a SMART system (Amersham Biosciences). Compounds were eluted with a linear gradient of 0-50% acetonitrile, 0.1% trifluoroacetic acid in 5.8 ml with a flow rate of 200 µl/min. The absorbance was measured simultaneously at 214, 260, and 280 nm to enable identification of oxidatively decarboxylated intermediates (7, 8). The fractions obtained were analyzed by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry (ESI-FTICR-MS) as described below.

High Resolution Mass Spectrometry-- ESI-FTICR-MS (19) measurements were carried out with a passively shielded 4.7-Tesla APEXTMII-ESI/matrix-assisted laser desorption ionization-FTICR mass spectrometer (Bruker Daltonik). The mass spectrometry software XMASS version 5.0.10 (Bruker Daltonik) was used for mass calculation, data acquisition, and processing. Mass calculation was performed with the standard elemental mass compilation of Audi and Wapstra (20). The measured mass range was m/z 200-2000, and broadband excitation took place from m/z 100 to 2000. In general, 524,288 data points were acquired. For positive ion investigations, 50 µl of methanol and 1% acetic acid were added to the sample solutions (~40-70-µl fractions from RPC). Electrospray ionization was performed in the positive mode with a grounded capillary sprayer needle mounted 60° off-axis (Analytica of Branford). No nebulizer gas was necessary to support the spray process. In general, the spectrum of a blank run (solvent and 1% acetic acid) was subtracted from the sample spectrum. For the external four-point calibration, standards derived from organic synthesis with the nominal masses m/z 201, 274, 342, and 364 were used.

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Purification of Mutant His-AtHAL3a Proteins-- AtHAL3a and mutant AtHAL3a genes were expressed as His-tag fusion proteins purified from the corresponding E. coli clones by immobilized metal affinity chromatography (IMAC) and additionally characterized by gel filtration (Figs. 1 and 2). All the mutant proteins have the same elution volume as wild-type His-AtHAL3a, and the ratio of the absorbance values at 280 and 450 nm was not significantly altered by the introduced mutations. We conclude that the introduced mutations do not affect the trimeric structure and coenzyme binding of AtHAL3a, indicating that the overall three-dimensional structure is not significantly altered. In the absence of DTT, trimeric His-AtHAL3a proteins oxidize and form higher multimers (Fig. 3).


View larger version (87K):
[in this window]
[in a new window]
 
Fig. 1.   Purification of mutant His-AtHAL3a proteins by IMAC. Purification of His-AtHAL3a and mutant His-AtHAL3a proteins was followed by SDS-PAGE. M, molecular weight marker. AtHAL3a is indicated with an arrow.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 2.   Gel filtration of mutant His-AtHAL3a proteins under reducing conditions. Immediately after elution from the Ni-NTA-agarose column, 5 mM DTT was added to the protein solutions. The IMAC-enriched His-AtHAL3a and mutant His-AtHAL3a proteins were then separated by gel filtration, and the elution was followed by absorbance at 280 nm (upper line), 378 nm (not shown), and 450 nm (lower line). The Superdex 200 PC 3.2/30 column used was calibrated with standard proteins to correlate the elution volume with molecular weight information as recently described (2). All the His-AtHAL3a proteins eluted at about 1.382 ml. This elution volume corresponds to an apparent molecular mass of about 110 kDa (5) and is in accordance with the trimeric structure of His-AtHAL3a-FMN (21).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 3.   Gel filtration of mutant His-AtHAL3a proteins under oxidizing conditions. IMAC-enriched His-AtHAL3a protein solutions containing no DTT were subjected to gel filtration after different times of incubation at 4 °C (His-AtHAL3a wt, 120 min; His-AtHAL3a N142D, 30 min; His-AtHAL3a C175S, 20 h; His-AtHAL3a G179A, 20 h). His-AtHAL3a wt containing 5 mM DTT was used in the control experiment. In the absence of DTT, His-AtHAL3a wt, N142D, and G179A oxidize and form higher multimers, whereas the elution volume of His-AtHAL3a C175S is not changed.

Mutations within the NH2-terminal Binding Helix of AtHAL3a-- Recent molecular characterization of CoaC activity showed that mutations within the NH2-terminal G(G/S)IAXYK motif of the Dfp proteins, especially the exchange of the residue Lys20 for Gln or Asn, decreased PPC decarboxylase activity (1). It was suggested that the conserved Lys residue is involved in binding of the phosphate group of PPC. This assumption is supported by the model for binding of PPC to AtHAL3a (5). Therefore, we were interested in characterizing the Lys34 residue within the motif GSVAAIK in the plant AtHAL3a protein. For the K34Q mutant, we could show a small decrease of PPC decarboxylase activity (Fig. 4). However, we also observed that exchange of the residue Lys34 for Asn or Gln led to an additional reaction product. This compound is only present in very low amounts if wild-type enzyme is used and, therefore, has not been detected before. Small amounts of this additional compound are also observed when the mutants I33V and K34R are used. Because we were aware that the synthetic PPC used is contaminated with pantothenoylcysteine, we decided to investigate if, in contrast to Dfp, AtHAL3a and mutant AtHAL3a proteins are able to decarboxylate PC (see below). We have previously shown that AtHAL3a is not as specific as Dfp (5).


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 4.   PPC decarboxylase activity of mutant AtHAL3a proteins. PPC was incubated with purified wild-type and mutant His-AtHAL3a proteins. The reaction mixtures were separated by RPC, and the elution was followed by absorbance at 214 nm. The reaction product PP eluted before PPC, as has been shown by electrospray ionization mass spectrometry (2). The mutant His-AtHAL3a proteins were analyzed under comparable conditions together with wild-type His-AtHAL3a in two sets of experiments (A, control, AtHAL3a wt, AtHAL3a V30I, AtHAL3a I33L, AtHAL3a I33V, and AtHAL3a K34N; B, AtHAL3a wt, AtHAL3a K34Q, AtHAL3a K34R, AtHAL3a R95Q, AtHAL3a N142D, AtHAL3a M145L, AtHAL3a A174S, AtHAL3a A174V, AtHAL3a C175S, AtHAL3a D177N, AtHAL3a G179A, and AtHAL3a G181A). The mutant His-AtHAL3a proteins N142D, M145L, and C175S showed no activity (only with high enzyme concentrations very low residual activities might be detectable), whereas AtHAL3a D177N and G179A very significantly reduced PPC decarboxylase activity. The mutant proteins A174S and G181A showed significantly reduced activity. An additional reaction product (labeled with an asterisk) was clearly detectable for the Lys34 mutants K34N and K34Q. However, minor amounts of this reaction product were also detectable for all active AtHAL3a mutants (including the R95Q mutant, data not shown) and wild-type enzyme. Further experiments showed that the substance labeled with an asterisk is pantothenoylcysteamine, which is derived from pantothenoylcysteine by decarboxylation (compare Fig. 5 and Fig. 7).

Pantothenoylcysteine Is Decarboxylated by AtHAL3a-- To analyze if AtHAL3a not only decarboxylates PPC but also PC, synthetic PC was incubated with wild-type and mutant His-AtHAL3a proteins. The reaction mixtures were then separated by RPC, and the masses of the eluted compounds were determined. AtHAL3a enzymes, which were active in decarboxylation of PPC, were also active in the decarboxylation of PC (Fig. 5). The mass difference between PC and the observed reaction product was determined to be 43.990 Da (not shown but see Fig. 6), which is in excellent agreement with the monoisotopic mass of CO2 (the calculated monoisotopic mass is 43.9898 Da). The reaction product pantothenoylcysteamine eluted with a retention time of about 24.0-24.2 min. This retention time is in agreement with that of the observed additional reaction product of the AtHAL3a K34N/K34Q reaction with synthetic PPC (see above; minor shifts in the overall retention times are explained by changes in the column material with increasing numbers of applications). We conclude that, in a mixture of PPC and PC, wt AtHAL3a preferentially decarboxylates PPC and that this discrimination between both substrates depends on Lys34. This is a direct hint that Lys34 of AtHAL3a binds the phosphate group of PPC. If no PPC is present, there should be no difference between AtHAL3a and AtHAL3a K34N/K34Q in the reaction with PC, because this substrate lacks the phosphate group (the data presented in Fig. 5 support this view). The elucidation of the kinetic parameters for AtHAL3a and AtHAL3a K34N/K34Q for both substrates is impeded by the lack of a suitable enzyme assay. Moreover, the determination of decarboxylase activities for different ratios of PPC and PC is only possible by separating the reaction products (as it is shown in Fig. 4).


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 5.   PC decarboxylase activity of mutant AtHAL3a proteins and detection of the oxidatively decarboxylated intermediate. D-Pantothenoylcysteine was incubated with IMAC-purified wild-type and mutant His-AtHAL3a proteins (AtHAL3a K34Q, AtHAL3a K34R, AtHAL3a R95Q, AtHAL3a N142D, AtHAL3a M145L, AtHAL3a A174S, AtHAL3a A174V, AtHAL3a C175S, AtHAL3a D177N, AtHAL3a G179A, and AtHAL3a G181A). The reaction mixtures were separated by RPC, and the elution was followed by absorbance at 214 nm (A), 260 nm (B), and 280 nm (data not shown). From the column used, PC eluted as a broad peak between 20 and 25 min. In the presence of active His-AtHAL3a enzymes, PC was converted to a compound (pantothenoylcysteamine, see Fig. 6) that eluted at about 24 min (corresponding to 13% acetonitrile; labeled with an asterisk). This compound is not present in the control reaction (PC incubated without any enzyme; not shown) and was not detected when the mutant His-AtHAL3a proteins N142D, M145L, and C175S were used. His-AtHAL3a A174S and G179A showed very low activity, whereas for D177N, the detection of the reaction product was only possible when higher enzyme concentrations were used. Interestingly, in the case of some of the mutants an additional compound eluted with a retention time of about 26-26.5 min. This compound (pantothenoylaminoethenethiol, see Fig. 6) showed an increased absorbance at 260 nm (B) and at 280 nm (not shown) and is labeled with an open circle in the figure (PC does not absorb at either 260 or 280 nm). Larger amounts of this compound were observed with the mutants R95Q, A174S, A174V, C175S, and G179A.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 6.   ESI-FTICR-MS analysis of the reaction products formed by His-AtHAL3a G179A. After incubation of D-pantothenoylcysteine with a high concentration of His-AtHAL3a G179A, the reaction mixture was separated by RPC (A), with the elution was followed by absorbance at 214 nm (thin line), 260 nm (thick line), and 280 nm (not shown). Compounds 2 and 3 are characterized by high absorbances at 260 and 280 nm (compound 2: A260/A214 = 2.23 and A260/A280 = 3.92). The masses of the peak fractions 1 and 2 were determined by ultrahigh resolution mass spectrometry (B and C, respectively). Fraction 1 is a mixture of PC and decarboxylated PC (pantothenoylcysteamine), whereas fraction 2 contains oxidatively decarboxylated pantothenoylcysteine (pantothenoylaminoethenethiol). Mass spectrometric analysis also indicates the presence of minor amounts of pantothenoylaminoethenethiol in fraction 3 (data not shown).

The Conserved Asn142 and Met145 Residues of the PXMNXXMW Motif-- The PXMNXXMW motif is conserved within the HFCD proteins, and crystal structure analysis of EpiD revealed the importance of this motif (residues 114-121 of EpiD) for binding of the substrate and the flavin cofactor (6). The conserved residue Asn117 of EpiD contacts the Cbeta hydrogen atoms and the carboxylate group of the substrate cysteinyl moiety. It appears that this Asn residue (EpiD, Asn117; MrsD, Asn125; Dfp, Asn125; AtHAL3a, Asn142) and the conserved His residue of the HCFD proteins (EpiD, His67; MrsD, His75; Dfp, His75; AtHAL3a, His90) are essential for the decarboxylase reaction. Met120 of EpiD is located above the pyrimidine system of the FMN cofactor. For the eubacterial enzyme Dfp, the importance of the conserved Asn and Met residues for the PPC decarboxylase activity has already been published (1, 2). To verify these data and the proposed model of PPC binding to AtHAL3a, the mutant proteins His-AtHAL3a N142D and His-AtHAL3a M145L were purified and characterized. As expected, both enzymes were inactive in decarboxylating PPC and PC (Figs. 4 and 5).

Mutations within the Substrate Recognition Clamp of AtHAL3a-- Recently, crystal structure analysis of EpiD H67N with bound peptide DSYTC revealed that the pentapeptide is embraced by a 20-amino acid substrate recognition clamp comprising residues Pro143 to Met162. Residues of the NH2-terminal binding helix, the residue Asn117, and the NHI motif (containing the above mentioned conserved His residue) are also important for substrate binding (6). We were interested in changing the way that PC and PPC bind to AtHAL3a to detect the oxidatively decarboxylated intermediate. Therefore, we not only exchanged Asn142 and residues of the NH2-terminal binding helix (see above) but also residues within the proposed PPC binding clamp of AtHAL3a. Characterization of the substrate recognition clamp of HFCD proteins by site-directed mutagenesis has not been published apart from the preliminary characterization of the conserved Cys residue of the PPC decarboxylases (1, 5). We mutated residues Ala174, Cys175 (see below), Gly179, and Gly181 of the AtHAL3a substrate recognition clamp Pro168-Ile-Lys-Lys-Arg-Leu-Ala174-Cys175-Gly-Asp-Ile-Gly179-Pro-Gly181-Arg-Met183 and elucidated the activity of the altered enzymes with both PPC and PC (Figs. 4 and 5). All of these residues are conserved in the eubacterial Dfp proteins (1). The mutant protein AtHAL3a D177N was included in the studies, because both AtHAL3a and E. coli Dfp have the ACGD motif, which is not present in the LanD enzymes EpiD and MrsD. Activity of AtHAL3a A174S, G179A, and G181A was significantly reduced with both substrates compared with wild-type AtHAL3a. D177N showed very low activity. However, activity of AtHAL3a A174V was comparable with wild-type activity, indicating that a hydrophobic side chain in position 174 is important for hydrophobic interactions with the substrate (compare the published model of PPC binding to AtHAL3a (5)). As described below, further characterization of the AtHAL3a G179A reaction with pantothenoylcysteine then led to the identification of the proposed intermediate.

Purification and Characterization of Oxidatively Decarboxylated Pantothenoylcysteine-- From the characterization of the flavoenzyme EpiD it was known that oxidatively decarboxylated peptidylcysteines are characterized by their absorbance properties. The aminoenethiol group NHCH==CHSH is a strong chromophore, and the UV spectra of the EpiD reaction products were pH-dependent, with an absorption maximum of 259 nm under acidic conditions (pH <=  4.2) for the enethiol form and 283 nm at pH 7.0 for the enethiolate form; the isosbestic point was determined to be 271 nm. It was shown that the molar extinction coefficient (epsilon ) of SFNSYVNHCH==CHSH at 259 nm is at least epsilon  approx  6,800 M-1cm-1 and that the pKa value of the enethiol group is about pH 6.0 (7). Therefore, the reversed phase separation of the AtHAL3a reaction mixtures was not only followed by absorbance at 214 nm but also by absorbance at 260 and 280 nm. Using PPC as substrate, we did not unambiguously detect compounds with an increased absorbance at 260 nm, even if mutant AtHAL3a proteins were used in the decarboxylation assay (data not shown). However, the combination of pantothenoylcysteine as a substrate and mutant His-AtHAL3a enzymes such as R95Q, A174S, A174V, C175S, D177N, and G179A enables the identification of a compound that showed strong absorption at 260 nm (Fig. 5B). The residues Ala174, Cys175, Asp177, and Gly179 are within the proposed substrate recognition clamp of AtHAL3a and could directly contact the substrate. Gly179 could also be important for the maintenance of the correct secondary/tertiary structure of the clamp. We believe that changing the structure of the recognition clamp results in a different active-site architecture and that the different geometry of the substrate/intermediate FMN/FMNH2 pair prevents complete reduction of the oxidatively decarboxylated intermediate by FMNH2. It is also possible that structural changes within the recognition clamp enables reoxidation of FMNH2 by oxygen. Modeling of PPC binding to AtHAL3a shows that also residue Arg-95 could contact the substrate (5).

The putative oxidatively decarboxylated PC (pantothenoylaminoethenethiol) was purified in larger amounts by incubation of PC with His-AtHAL3a G179A, because incubation with this enzyme led to the largest amounts of the intermediate. After separation of the reaction mixture by RPC, the reaction products were analyzed by ESI-FTICR-MS (Fig. 6). The MS data prove that PC is decarboxylated to pantothenoylcysteamine and that the compound with increased absorbance at 260 nm (and 280 nm) is pantothenoylaminoethenethiol. Interestingly, a second compound with the mass of pantothenoylaminoethenethiol could also be detected, and we propose that the two compounds are cis and trans isomers of the aminoenethiol intermediate.

The Conserved Cys175 Residue of the Substrate Binding Clamp-- Recently, it has been shown that the conserved Cys residue of the substrate recognition clamp of Dfp proteins, which is missing in the LanD enzymes EpiD, MrsD, and MutD (6), is essential for activity (1, 5). We could prove this for AtHAL3a, because His-AtHAL3a C175S is inactive in decarboxylation of PPC to PP and of PC to pantothenoylcysteamine (Figs. 4 and 5). However, we detected pantothenoylaminoethenethiol when this mutant His-AtHAL3a enzyme was incubated with PC (Fig. 5B). Therefore, the C175S mutant differs from the R95Q, A174S, A174V, D177N, and G179A mutants, which were able to reduce the oxidized intermediate but had a very low decarboxylase activity (Figs. 4 and 5). These mutants are probably substrate binding mutants. We suggest that Cys175 is directly involved in the reaction mechanism by reoxidation of the FMNH2 cofactor and/or by reduction of the oxidized intermediate (Fig. 7). Oxidation of the thiol side chain of the substrates would still be possible with the C175S mutant (if Cys175 has the proposed function), and consequently, spontaneous decarboxylation occurs. However, the reduced coenzyme will not be reoxidized by the substrate so that the native reaction cycle is interrupted, and only oxidatively decarboxylated but no decarboxylated compounds are detectable. Partial reoxidation of FMNH2 by oxygen can explain the fact that oxidatively decarboxylated intermediates are present in greater molar amounts than the enzyme used. Because C175 itself is part of the substrate recognition clamp, the previously mentioned structural changes of the clamp, for example the G179A exchange, not only change the binding of the reaction intermediate but also the geometry between reduced coenzyme, Cys175, and the intermediate.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 7.   Reaction mechanism of the decarboxylation of pantothenoylcysteine catalyzed by AtHAL3a. Recently, it has been suggested that Calpha -Cbeta dehydrogenation is not the initial reaction of the LanD proteins EpiD and MrsD but, rather, oxidation of the thiol group by FMN. In this mechanism a thioaldehyde group-containing intermediate is formed, and its spontaneous decarboxylation (in analogy to the decarboxylation of beta -keto acids) leads to the peptidylaminoenethiolate/peptidylaminoenethiol reaction product (6). However, in case of the PPC decarboxylases it is not the aminoenethiolate compound but the cysteamine derivative that is the final product. The results presented in this paper clearly demonstrate that the decarboxylation of pantothenoylcysteine follows the oxidative decarboxylation mechanism of the LanD proteins, since oxidatively decarboxylated PC could be identified by mass spectrometry and UV-visible spectroscopy. The enethiol/enethiolate intermediate is then reduced by FMNH2 completing the reaction cycle. The reaction of AtHAL3a C175S with PC does not lead to pantothenoylcysteamine (decarboxylated PC). However, pantothenoylaminoethenethiol (oxidatively decarboxylated PC) was detectable, and therefore, it is reasonable to assume that Cys175 is involved in the oxidation of FMNH2 and/or reduction of the aminoenethiol intermediate. Furthermore, this Cys residue is conserved in the eubacterial Dfp proteins, and it has been shown that Dfp C158A and Dfp C158S are inactive in the decarboxylation of PPC to PP (1,5). However, the exact catalytic role of the conserved Cys residue remains open for further investigations. We assume that the decarboxylation mechanism is not dependent of the used substrate (PC or PPC). However, the oxidatively decarboxylated intermediate was present in assignable amounts for PC but not for PPC. This probably reflects the fact that PPC is more tightly bound by the enzyme, and therefore, changes within the substrate binding clamp do not influence the second half reaction of the flavoenzyme to the same extent.

The elucidation of the mechanism of the second half reaction of the PPC decarboxylases will require further detailed biochemical and structural studies. However, it is tempting to speculate that the aminoenethiol/enethiolate group of the intermediate, NHCH==CHSH, and the side chain of Cys175, CH2SH, form the mixed disulfide NHCH2CH2SSCH2 during one stage of the second half reaction of the PPC decarboxylases. In this model, we suggest that disulfide formation concurs with reduction of the double bond, although the mechanism of this reaction is not clear. The disulfide is finally reduced by FMNH2, generating the cysteamine residue of the substrate and restoring the thiol side chain of Cys175.

Interestingly, in contrast to wild-type AtHAL3a and other mutants, trimeric AtHAL3a C175S cannot form dimers (of trimers) under oxidizing conditions (Fig. 3). In the absence of a substrate, the recognition clamp has no defined structure (6), and Cys175 could form intermolecular disulfide bridges.

Conclusions-- In this paper, we have shown that the plant flavoprotein AtHAL3a not only decarboxylates PPC but also PC and that the discrimination between both substrates involves the conserved Lys34 residue. We were able to show that pantothenoylaminoethenethiol is the intermediate in decarboxylation of PC. We conclude that the decarboxylation of PC and PPC follows the mechanism decarboxylation by initial oxidation (Fig. 7). The role of the flavin cofactor of the PPC decarboxylases AtHAL3a and Dfp is therefore the same as for the LanD enzymes EpiD and MrsD. However, it appears that the difference in structure of the substrate binding clamp of PPC decarboxylases compared with LanD enzymes (for example the presence of the ACGD motif in the PPC decarboxylases) not only causes the difference in substrate specificity but also a different overall reaction. PPC decarboxylases are able to reduce the aminoenethiol group to a cysteamine residue, whereas LanD decarboxylases are not able to reoxidize their flavin cofactor in this way. Starting with the characterization of the peptidylcysteine decarboxylase EpiD a decade ago, we now understand how the decarboxylation of Cys residues occurs.

    ACKNOWLEDGEMENTS

We thank Regine Stemmler for excellent technical assistance, Michael Uebele for synthesis of (R)-4'-phospho-N-pantothenoylcysteine and D-pantothenoylcysteine, and Lloyd Ruddock for reading the manuscript.

    FOOTNOTES

* This work was supported by Deutsche Forschungsgemeinschaft Grant KU869/6-1 (to T. K.) and by European Molecular Biology Organization Fellowship ASTF 9878 (to P. H.-A.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence and reprint requests should be addressed. E-mail: Thomas.Kupke@t-online.de.

Published, JBC Papers in Press, March 28, 2002, DOI 10.1074/jbc.M201557200

    ABBREVIATIONS

The abbreviations used are: PPC, (R)-4'-phospho-N-pantothenoylcysteine; PP, 4'-phosphopantetheine; HFCD, homo-oligomeric flavin-containing Cys decarboxylases; PC, D-pantothenoylcysteine; Ni-NTA, nickel nitrilotriacetic acid, His-AtHAL3a, MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGS-AtHAL3a; DTT, dithiothreitol; RPC, reversed phase chromatography; ESI-FTICR-MS, electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry; IMAC, immobilized metal affinity chromatography; wt, wild type.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

1. Kupke, T. (2001) J. Biol. Chem. 276, 27597-27604[Abstract/Free Full Text]
2. Kupke, T., Uebele, M., Schmid, D., Jung, G., Blaesse, M., and Steinbacher, S. (2000) J. Biol. Chem. 275, 31838-31846[Abstract/Free Full Text]
3. Strauss, E., Kinsland, C., Ge, Y., McLafferty, F. W., and Begley, T. P. (2001) J. Biol. Chem. 276, 13513-13516[Abstract/Free Full Text]
4. Espinosa-Ruiz, A., Bellés, J. M., Serrano, R., and Culiáñez-Macià, F. A. (1999) Plant J. 20, 529-539[CrossRef][Medline] [Order article via Infotrieve]
5. Kupke, T., Hernández-Acosta, P., Steinbacher, S., and Culiáñez-Macià, F. A. (2001) J. Biol. Chem. 276, 19190-19196[Abstract/Free Full Text]
6. Blaesse, M., Kupke, T., Huber, R., and Steinbacher, S. (2000) EMBO J. 19, 6299-6310[CrossRef][Medline] [Order article via Infotrieve]
7. Kupke, T., and Götz, F. (1997) J. Biol. Chem. 272, 4759-4762[Abstract/Free Full Text]
8. Kupke, T., Kempter, C., Gnau, V., Jung, G., and Götz, F. (1994) J. Biol. Chem. 269, 5653-5659[Abstract/Free Full Text]
9. Kupke, T., Kempter, C., Jung, G., and Götz, F. (1995) J. Biol. Chem. 270, 11282-11289[Abstract/Free Full Text]
10. Kupke, T., Stevanovic, S., Sahl, H.-G., and Götz, F. (1992) J. Bacteriol. 174, 5354-5361[Abstract/Free Full Text]
11. Majer, F., Schmid, D. G., Altena, K., Bierbaum, G., and Kupke, T. (2002) J. Bacteriol. 184, 1234-1243[Abstract/Free Full Text]
12. Sahl, H.-G., and Bierbaum, G. (1998) Annu. Rev. Microbiol. 52, 41-79[CrossRef][Medline] [Order article via Infotrieve]
13. Schnell, N., Entian, K.-D., Schneider, U., Götz, F., Zähner, H., Kellner, R., and Jung, G. (1988) Nature 333, 276-278[CrossRef][Medline] [Order article via Infotrieve]
14. Kempter, C., Kupke, T., Kaiser, D., Metzger, J. W., and Jung, G. (1996) Angew. Chem. Int. Ed. Engl. 35, 2104-2107
15. Spitzer, E. D., and Weiss, B. (1985) J. Bacteriol. 164, 994-1003[Abstract/Free Full Text]
16. Strauss, E., and Begley, T. P. (2001) J. Am. Chem. Soc. 123, 6449-6450[CrossRef][Medline] [Order article via Infotrieve]
17. Cormack, B. (1991) in Current Protocols in Molecular Biology (Ausubel, F. M. , Brent, R. , Kingston, R. E. , Moore, D. D. , Seidman, J. G. , Smith, J. A. , and Struhl, K., eds), Vol. 1 , pp. 8.5.1.-8.5.9, John Wiley & Sons, Inc., New York
18. Schägger, H., and Jagow, G. (1987) Anal. Biochem. 166, 368-379[CrossRef][Medline] [Order article via Infotrieve]
19. Marshall, A. G., Hendrickson, C. L., and Jackson, G. S. (1998) Mass Spectrom. Rev. 17, 1-35[CrossRef][Medline] [Order article via Infotrieve]
20. Audi, G., and Wapstra, A. H. (1995) Nucl. Phys. A 595, 409-480[CrossRef]
21. Albert, A., Martinez-Ripoll, M., Espinosa-Ruiz, A., Yenush, L., Culiáñez- Macià, F. A., and Serrano, R. (2000) Structure Fold. Des. 8, 961-969[Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Kupke and W. Schwarz
4'-Phosphopantetheine Biosynthesis in Archaea
J. Biol. Chem., March 3, 2006; 281(9): 5435 - 5444.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
S. Rubio, T. R. Larson, M. Gonzalez-Guzman, S. Alejandro, I. A. Graham, R. Serrano, and P. L. Rodriguez
An Arabidopsis Mutant Impaired in Coenzyme A Biosynthesis Is Sugar Dependent for Seedling Establishment
Plant Physiology, March 1, 2006; 140(3): 830 - 843.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Munoz, A. Ruiz, M. Marquina, A. Barcelo, A. Albert, and J. Arino
Functional Characterization of the Yeast Ppz1 Phosphatase Inhibitory Subunit Hal3: A MUTAGENESIS STUDY
J. Biol. Chem., October 8, 2004; 279(41): 42619 - 42627.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Ruiz, I. Munoz, R. Serrano, A. Gonzalez, E. Simon, and J. Arino
Functional Characterization of the Saccharomyces cerevisiae VHS3 Gene: A REGULATORY SUBUNIT OF THE Ppz1 PROTEIN PHOSPHATASE WITH NOVEL, PHOSPHATASE-UNRELATED FUNCTIONS
J. Biol. Chem., August 13, 2004; 279(33): 34421 - 34430.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. R. Tulman, C. L. Afonso, Z. Lu, L. Zsak, G. F. Kutish, and D. L. Rock
The Genome of Canarypox Virus
J. Virol., January 1, 2004; 78(1): 353 - 366.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kupke, P. Hernandez-Acosta, and F. A. Culianez-Macia
4'-Phosphopantetheine and Coenzyme A Biosynthesis in Plants
J. Biol. Chem., October 3, 2003; 278(40): 38229 - 38237.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kupke
Molecular Characterization of the 4'-Phosphopantothenoylcysteine Synthetase Domain of Bacterial Dfp Flavoproteins
J. Biol. Chem., September 20, 2002; 277(39): 36137 - 36145.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/23/20490    most recent
M201557200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hernández-Acosta, P.
Right arrow Articles by Kupke, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hernández-Acosta, P.
Right arrow Articles by Kupke, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us